| 规格: | 98% |
| 分子量: | 1581.41 |
| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
Background:
DB550 targets PLCγ1 and disrupts the CD95-PLCγ 1 interaction to prevent Th17-driven inflammation, without affecting the CD95-FADD interaction[1]. PLCγ1[1].
[1]. Poissonnier A, et al. Disrupting the CD95-PLCγ1 interaction prevents Th17-driven inflammation. Nat Chem Biol. 2018 Dec;14(12):1079-1089.
